Novel inhibitors of 5α-reductase

Expert Opinion on Therapeutic Patents

Volumn 12, Issue 2, 2002, Pages 201-215

  Machetti, Fabrizio ^a   Guarna, Antonio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

5 reductase; Acne; Alopecia; Benign prostatic hyperplasia; Enzyme inhibitors; Hirsutism; Prostate cancer; Steroids

Indexed keywords

17BETA (N,N DIETHYLCARBAMOYL) 4 METHYL 4 AZA 5ALPHA ANDROSTAN 3 ONE; 4,7BETA DIMETHYL 4 AZACHOLESTAN 3 ONE; ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; ANTIANDROGEN; AZASTEROID; AZULENE DERIVATIVE; BENZIMIDAZOLE DERIVATIVE; BIPHENYL DERIVATIVE; BUTYRIC ACID DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; COUMARIN DERIVATIVE; DUTASTERIDE; FINASTERIDE; INDOLE DERIVATIVE; MELAPI EXTRACT; N [2,2,2 TRIFLUORO 1 PHENYL 1 (TRIFLUOROMETHYL)ETHYL] 3 OXO 4 AZA 5ALPHA ANDROST 1 ENE 17BETA CARBOXAMIDE; PLANT EXTRACT; PYRIDONE DERIVATIVE; QUINOLIZINE DERIVATIVE; STEROID 5ALPHA REDUCTASE; STEROID 5ALPHA REDUCTASE INHIBITOR; TESTOSTERONE; THUJA EXTRACT; TUROSTERIDE; UMBELLIFERONE DERIVATIVE; UNCLASSIFIED DRUG;

ACNE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; DISEASE SEVERITY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG WITHDRAWAL; FEMALE; HIRSUTISM; HUMAN; HUMAN CELL; LIVER DISEASE; MALE; MALE TYPE ALOPECIA; MELAPI; NONHUMAN; OVARY POLYCYSTIC DISEASE; PLANT; PROSTATE CANCER; PROSTATE HYPERTROPHY; RAT; REVIEW; SKIN DISEASE; STRUCTURE ACTIVITY RELATION; THUJA;

EID: 0036169261     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.12.2.201     Document Type: Review

References (54)

1. Characterization of 5α-reductase gene expression in stroma and epithelium of human prostate
2. Steroid 5α-reductase deficiency in man: An inherited form of male pseudohermaphroditism
3. Inhibitors of steroid 5α-reductase in benign prostatic phyperplasia, male pattern baldness and acne
4. Inhibition of steroid 5α-reductase
5. Steroidal and non-steroidal inhibitors of steroid 5α-reductase
6. The enzyme and inhibitors of 4-ene-3-oxosteroid 5α-oxidoreductase
7. Pharmacological options in the treatment of benign prostatic hyperplasia
8. Inhibitors of 5α-reductase
9. Clinical application of 5α-reductase inhibitors
10. Androgen metabolism as it affects hair growth in androgenetic alopecia
11. Male pattern baldness
12. Treatment options for benign prostatic hyperplasia
13. Clinical relevance of testosterone and dihydrotestosterone metabolism in women
14. Idiopathic hirsutism
15. Comparison of finasteride and flutamide in the treatment of idiopathic hirsutism
16. A prospective, randomized trial comparing flutamide (250mg/d) and finasteride (5mg/d) in the treatment of hirsutism
17. Role of 5α-reductase inhibitors in the treatment of advanced prostatic carcinoma
18. The role of steroid hormones in prostate carcinogenesis
19. Stable expression of human 5α-reductase Type II in COS1 cells due to chromosomal gene integration: A novel tool for inhibitor identification
20. Azasteroids as inhibitors of rat prostatic 5α-reductase
21. Azasteroids: Structure-activity relationships for inhibition of 5α-reductase and of androgen receptor binding
22. Finasteride
23. Effect of finasteride on adrenal steroidogenesis in men
24. Mechanism-based inhibition of human steroid 5α-reductase by Finasteride: Enzyme-catalyzed formation of NADP-dihydrofinasteride, a potent bisubstrate analog inhibitor
25. 6-Azasteroids: Potent dual inhibitors of human Type 1 and 2 steroid 5α-reductase
26. 6-Azasteroids: Structure-activity relationships for inhibition of Type 1 and 2 human 5α-reductase and human adrenal 3 β-hydroxy-δ 5-steroid dehydrogenase/3-keto-δ 5-steroid isomerase
27. 19-nor-10-azasteroids: A novel class of inhibitors for human steroid 5α-reductases 1 and 2
28. 19-Nor-10-azasteroids, a new class of steroid 5α-reductase inhibitors: 2. x-ray structure, molecular modeling, conformational analysis of 19-nor-10-azasteroids and comparison with 4-azasteroids and 6-azasteroids
29. A concise route to 19-nor-10-azasteroids, a new class of steroid 5α-reductase inhibitors. 3. Synthesis of (+)-19-nor-10-azatestosterone and (+)-17β-(acetyloxy)-5β-10-azaestr-1-en-3-one
30. 1(2)-19-nor-10-azasteroids. 4
31. 17,20-lyase)
32. Epristeride is a selective and specific uncompetitive inhibitor of human steroid 5α-reductase isoform 2
33. Inhibition of steroid 5α-reductase by unsaturated 3-carboxysteroids
34. Inhibition of rat liver steroid 5α-reductase by 3-androstene-3-carboxylic acids: Mechanism of enzyme-inhibitor interaction
35. Benzo[c]quinolizin-3-ones: A novel class of potent and selective nonsteroidal inhibitors of human steroid 5α-reductase 1
36. Synthesis and evaluation of novel steroidal oxime inhibitors of P450 17 (17α- hydroxylase/C17-20-Lyase) and 5α-reductase types 1 and 2
37. Finasteride: An update of its use in the management of symptomatic benign prostatic hyperplasia
38. Androgen ablation and blockade in the treatment of benign prostatic hyperplasia
39. MK-386, an inhibitor of 5α-reductase Type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen
40. Effect of turosteride, a 5α-reductase inhibitor, on the Dunning R3327 rat prostatic carcinoma
41. 4-Aza-3-oxo-5α-androst-1-ene- 17 β-N-aryl-carboxamides as dual inhibitors of human Type 1 and Type 2 steroid 5α-reductases. Dramatic effect of N-aryl substituents on Type 1 and Type 2 5α-reductase inhibitory potency
42. 4,7 β-Dimethyl-4-azacholestan-3-one (MK-386) and related 4-azasteroids as selective inhibitors of human Type 1 5 α-reductase
43. FCE 28260 a new 5α-reductase inhibitor: In vitro and in vivo effects
44. PNU157706, a novel dual Type I and II 5α-reductase inhibitor
45. Synthesis and 5α-reductase inhibitory activity of 8-substituted benzo[f]quinolinones derived from palladio mediated coupling reactions
46. Effect of C-ring modifications in benzo[c]quinolizin-3-ones, new selective inhibitors of human 5α-reductase 1
47. 3-Carboxy-20-keto steroids are dual uncompetitive inhibitors of human steroid 5α-reductase types 1 and 2
48. Indole and benzimidazole derivatives as steroid 5α-reductase inhibitors in the rat prostate
49. N-Substituted 4-(5-indolyl)benzoic acids. Synthesis and evaluation of steroid 5α-reductase Type I and II inhibitory activity
50. Synthesis of N-substituted piperidine-4-(benzylidene-4-carboxylic acids) and evaluation as inhibitors of steroid-5α-reductase Type 1 and 2
51. Biphenyls as surrogates of the steroidal backbone. Part 1: Synthesis and estrogen receptor affinity of an original series of polysubstituted biphenyls
52. Biphenyls as surrogates of the steroidal backbone. Part 2: Discovery of a novel family of non-steroidal 5-α-reductase inhibitors
53. A novel class of inhibitors for steroid 5α-reductase: Synthesis and evaluation of umbelliferone derivatives
54. 1-adrenoreceptor antagonist and steroid 5α-reductase inhibitory activities. Synthesis and evaluation of arylpiperazine derivatives